Stevenage, United Kingdom

Rudolf Maria De Wildt

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rudolf Maria De Wildt

Introduction

Rudolf Maria De Wildt, an accomplished inventor based in Stevenage, GB, has made significant strides in the field of biomedicine. With a remarkable portfolio of two patents, he has focused on developing innovative solutions for various medical conditions, particularly those associated with TGF-beta signaling and dendritic cell targeting.

Latest Patents

Rudolf's latest patents showcase his dedication to advancing medical treatment options. One notable patent involves the development of ligands that bind to the TGF-beta receptor RII. This disclosure provides an anti-TGFbetaRII immunoglobulin single variable domain and outlines a polypeptide, ligand, or pharmaceutical composition aimed at treating diseases related to TGF-beta signaling. These conditions include tissue fibrosis, liver fibrosis, rheumatoid arthritis, ocular disorders, and vascular conditions such as restenosis.

His second patent centers around a composition designed for targeting dendritic cells. This innovative composition includes one or more antigens, an anti-DC-SIGN immunoglobulin single variable domain, and a carrier that encapsulates these components. This patent emphasizes formulations and devices incorporating such anti-DC-SIGN molecules, specifically for use as a medicament in cancer treatment, especially melanoma.

Career Highlights

Rudolf has made his mark in significant corporate settings, having worked with renowned companies such as Glaxo Group Limited and Lipotek Pty Ltd. His experience in these organizations has provided him with a robust foundation to drive his innovations and contribute to the advancement of medical science.

Collaborations

Throughout his career, Rudolf has collaborated with talented professionals, including Caroline Dimech and Adriaan Allart Stoop. These partnerships have not only enriched his work but also fostered a collaborative environment for innovation and excellence in research and development.

Conclusion

Rudolf Maria De Wildt exemplifies the spirit of innovation in the realm of biomedicine. His patents reflect a profound commitment to addressing critical health challenges through scientific advancements. As he continues to collaborate with peers in the industry, his contributions will undoubtedly pave the way for future breakthroughs in medical treatments and enhance the quality of care for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…